Scientist Arjan Griffioen leads cancer treatment innovation with lab and startup (Amsterdam UMC)
Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential funding and investment. Spoiler alert: bringing the new treatment to market is not done overnight! Curious about the steps necessary? Watch the video to hear the full story by Arjan Griffioen and Else Huijbers.
Explore other Stories:
Stories of Physics2Market Fund
The Physics2Market fund offered researchers the opportunity to take physics research from lab to society. For example, by building a prototype or proof-of-concept study, collaborations with companies emerged. Raoul Frese – assistant professor at the Faculty of Science, Biophysics Photosynthesis/Energy at Vrije Universiteit Amsterdam – received the last Physics2Market subsidy to further develop material to […]
Define your short and long term value
In valorisation, it is very important to think carefully about the exchange of values between the organizations you work with and the team of scientists
Dr. Kostenko on finding a team and funding for start-ups
How do you create a team and find financial support when you launch a start-up? IXA talked to postdoctoral researcher and entrepreneur Alexander Kostenko. When Alexander launched his start-up Photosynthetic in 2019 to build a new kind of 3D printer, he didn’t have a team yet, nor financial resources. Now, he has found a team […]